zDHHC3 is also known to modulate the S-palmitoylation of programmed cell death ligand 1 (PD-L1), and the blocking of PD-L1 S-palmitoylation increased the sensitivity of tumor cells to T-cell cytotoxicity (Yao et al. 2019). Here, ZDHHC3 is linked to neoplasm.